As a valued TearCare® owner...
Take a look at Dry Eye Rescue

Treating Dry Eye Disease (DED) starts with Meibomian Gland Disease (MGD)

Your Peers Agree, Obstruction is a Catalyst for MGD-related Dry Eye

87% believe obstruction is a key component of MGD1
71% state obstruction removal should be the first-line treatment for patients with MGD1
Yet only 5.2% of patients receive thermal expression treatment2

Let us help you be successful with TearCare® and get a special opportunity from Dry Eye Rescue!
Request a call for more information.

The Future is Clear

To address evaporative dry eye, you have to target the underlying cause—MGD. The TearCare® System is a heat and expression device designed to leverage intelligent therapeutic heat and your expertise in expression to evacuate obstructions.

Exclusive Dry Eye Rescue offer for offices with the TearCare® System. Save $500 on Medium Starter Package with code TearCareDER

References:

  1. PentaVision LLC. (2021). Survey of Optometrists and Ophthalmologists (October – November 2020 and January- April 2021). [Data on file]. PentaVision LLC.
  2. Market Scope 2021 Ocular Surface Disease Survey

Indications for Use: The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. 
The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.

SightSciences_Logo_White_2410x880
  • 4040 Campbell Ave, Suite 100
  • Menlo Park CA 94025
  • T: 877-266-1144

© 2022 Sight Sciences, Inc.      3/22      TC-2270-US.v1